Abstract
Aim Hypertension with non-dipper or reverse dipper patterns has worse outcomes. Smokers have some risk factors for abnormal dipping. There are conflicting results about the association between smoking and blood pressure (BP) dipping patterns, thus we aimed to examine it in essential hypertension.
Methods 178 essential hypertension patients (ages 30-83) completed Fagerström Nicotine Dependence Test (FNDT) and our custom Patient Data Collection Test (PDCT). We analyzed these data with the ambulatory BP measurements (ABPM) and performed logistic regression analysis.
Results Abnormal dipping patterns were significantly more frequent among patients with a history of smoking (75,0%) than those without history of smoking (47,4%), (p<0,001). Among smokers, abnormal dipping patients had significantly higher FNDT Scores (5 (0-10) versus 2 (0-9), p=0,046), longer smoking years (25 (6-50) versus 20 (5-50), p=0,017), and more smoking exposure in terms of pack.years (25 (3-135) versus 15 (1-75), p=0,023). Patients with history of smoking had significantly higher nocturnal systolic (128,10±15,54 versus 120,56±12,84 mmHg, p=0,001), nocturnal diastolic (80,82±12,60 versus 76,44±10,89 mmHg, p=0,016), and 24-hour mean systolic (133,15±13,52 versus 127,90±12,03 mmHg, p=0,008) BP values; and more blunted systolic and diastolic dipping ratios than non-smokers. Patients with a history of smoking were 3,484 (1,693-7,171 CI:0,95 p=0,001) times more likely to have abnormal dipping. Smoking was also associated with diabetes mellitus, dyslipidemia, and metabolic syndrome.
Conclusion Smoking was associated with abnormal dipping patterns; higher nocturnal systolic, diastolic, and 24-hour systolic BP values; and lower systolic and diastolic dipping rates. FNDT score and smoking exposure parameters were significantly higher in abnormal dipping.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
We performed the research with the permission of Ethical Committee of Ankara Sanatorium Research and Education Hospital. We did not have permission to upload the data to ClinicalTrials.gov.
Funding Statement
We did not receive any fundings.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Medical Ethics Committe of Ankara Sataorium Research and Education Hospital
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos